Comparative Pharmacology
Head-to-head clinical analysis: ZEFAZONE versus ZEFAZONE IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ZEFAZONE versus ZEFAZONE IN PLASTIC CONTAINER.
ZEFAZONE vs ZEFAZONE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
ZEFAZONE is a cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
Cephalosporin antibiotic; inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking.
1 g IV/IM every 8 hours for moderate to severe infections; 2 g IV/IM every 8 hours for life-threatening infections.
1 to 2 g intravenously every 6 to 8 hours depending on infection severity.
None Documented
None Documented
1.5-2 hours in normal renal function; prolonged to 20-30 hours in severe renal impairment (CrCl <10 mL/min), necessitating dose adjustment
Terminal elimination half-life ~1.5 hours in normal renal function; prolonged in renal impairment (up to 20-30 hours in anuria).
Primarily renal (80-90% unchanged via glomerular filtration and tubular secretion); minor biliary excretion (10-20%)
Primarily renal, 70-80% excreted unchanged in urine via glomerular filtration and tubular secretion; 20-30% biliary excretion with fecal elimination.
Category C
Category C
First-Generation Cephalosporin
First-Generation Cephalosporin